Samuel Arends

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Christa Walgaard, Bart C. Jacobs, Hester F. Lingsma et al. · The Lancet Neurology · 2021 · 103 citations · Full text

Immunodeficiencies, Immunology, Placebo-controlled Trial +4

Predictive value of electroencephalography in anti-NMDA receptor encephalitis

Agnes van Sonderen, Samuel Arends, D.L.J. Tavy et al. · Journal of Neurology Neurosurgery & Psychiatry · 2018 · 85 citations

An International Perspective on Preceding Infections in Guillain-Barré Syndrome

Sonja E. Leonhard, Annemiek A. van der Eijk, Henning Andersen et al. · Neurology · 2022 · 76 citations · Full text

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study

Linda W.G. Luijten, Sonja E. Leonhard, Annemiek A. van der Eijk et al. · Brain · 2021 · 72 citations · Full text

Recruitment Bias, World Health Organization, Long Covid +12

CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome

Helle Al-Hakem, Alex Y. Doets, Amro Stino et al. · Neurology · 2023 · 51 citations · Full text